The Ministry of Health registered the vaccine «Allergarda» against birch pollen allergy before completion of Phase III trials
The Russian Ministry of Health registered the vaccine against birch pollen allergy «Allergarda» before completion of Phase III clinical trials. In the results of Phases I–II published in September, researchers described five cases of grade 3 anaphylaxis; all patients received treatment and recovered without consequences.
#Allergard #Generium #MinzdravRossii #Nanolek #birchpollen #FMBA